Clinical trial

MMF vs. AZA for Kidney Transplantation

NCT00494741 · Mario Negri Institute for Pharmacological Research, Other · Completed

Key facts

NCT number NCT00494741
Title MMF vs. AZA for Kidney Transplantation
Official title A Randomized, Prospective, Multicenter Trial to Compare the Effect on Chronic Allograft Nephropathy Prevention of Mycophenolate Mofetil Versus Azathioprine as the Sole Immunosuppressive Therapy for Kidney Transplant Recipients
Acronym ATHENA
Lead sponsor Mario Negri Institute for Pharmacological Research, Other
Collaborators Agenzia Italiana del Farmaco
Status Completed
Phase Phase 4
Study type Interventional
Conditions Kidney Transplant
Intervention type Drug
Interventions mycophenolate mofetil, azathioprine
Enrollment 233
Start date May 1, 2007
Primary completion Jul 1, 2016
Completion Nov 29, 2017
First posted Jul 2, 2007
Last update posted Dec 13, 2017
Countries Italy

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies